A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy

NCT00907608 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped Due to difficulty in patient recruitment

Conditions

Diabetes Mellitus
Chronic Kidney Disease
Anemia

Interventions

DRUG: Darbepoetin alfa

Sponsor

Chinese University of Hong Kong